A small biomedical research charity creating accessible treatments through repurposed drugs to ease suffering
Gillies McIndoe Research Institute is dedicated to transforming lives through innovative and accessible biomedical research. Located at 7 Hospital Road, Level 3, Wellington, WGN 6021, NZ, Gillies McIndoe Research Institute focuses on developing life-changing treatments for challenging conditions such as brain cancer, vascular birthmarks, and keloid scars. The institute’s mission is to ease suffering and expand access to care through the strategic repurposing of existing drugs, ensuring affordable and effective solutions.
Utilizing advanced techniques including spheroids, organoids, proteomics, and metabolomics, Gillies McIndoe Research Institute conducts groundbreaking research with an internationally recognized team. By closely mimicking human biology in testing environments, the institute ensures precise and impactful discoveries. Gillies McIndoe Research Institute bridges in vitro methodologies with physiology, clinical trials, and advanced organoid models to translate scientific breakthroughs into real-world healthcare solutions, aiming to reduce the need for invasive surgeries and harsh treatments.
Gillies McIndoe Research Institute is committed to scientific rigor, collaboration, and innovation, striving to push the boundaries of science for a healthier, more hopeful future. The institute’s work has the potential to bring hope and healing within reach for all. Gillies McIndoe Research Institute welcomes partners who share a commitment to advancing research that changes lives. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform.
Compare Gillies McIndoe Research Institute with 3 companies in Biotechnology-Research
| Comparison Field |
Gillies McIndoe Research...Main Company |
Virogin BiotechView Profile |
Qu Biologics Inc.View Profile |
MtoZ BiolabsView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2015 | 2007 | |
|
Company Size
|
— | 51-200 | 11-50 | 11-50 |
|
City
|
Wellington, WGN | Richmond, British Columbia | Burnaby, British Columbia | Boston, MA |
|
Country
|
New Zealand | Canada | Canada | United States |
|
Skills & Keywords
Comparing with main company
|
24 Total Skills
Biotechnology Research
Drug Repurposing
Brain Cancer Research
Vascular Birthmarks
Keloid Scars Treatment
Organoid Models
Proteomics
confocal microscopy
metabolomics
fibrotic conditions
commercialisation
disease prevention
Postgraduate education
novel organoid models
drug repurpose
cancer
disease management
vascular anomolies
clinical trials
biology
histology
biotechnology
immunohistochemistry
proteomics
|
8 Total
8 Unique
Unique Skills:
biochemistry
immuno-oncology
immunotherapy
innovation
oncology
r&d
+2
|
17 Total
17 Unique
Unique Skills:
arthritis
autoimmune diseases
autoimmune disorders
biologics
biotech
COVID
+11
|
13 Total
13 Unique
Unique Skills:
bioinformatics
biopharmaceutics
iTRAQ/TMT
Label-free
lipidomics
MRM
+7
|
Other organizations in the same industry
This company is also known as